Impact of comorbidities on Migraine quality of life:Cross-sectional study using receipt data and questionnaire survey
Not Applicable
- Conditions
- Migraine
- Registration Number
- JPRN-UMIN000050349
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Brief Summary
The results suggest that the factors influencing MS-QOL were cerebrovascular depression for RR and RP, schizophrenia and sleep disorders for EF. The number of comorbidities did not influence MS-QOL by the number of comorbidities. Factors influencing WPAI were sleep disorders in presenteeism and overall work impairment, and depression in activity impairment. The number of comorbidities did not influence the WPAI in terms of the number of comorbidities.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 674
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MS-QOL(Migraine-Specific Quality of Life)
- Secondary Outcome Measures
Name Time Method WPAI(Work Productivity and Activity Impairment)